Interesting read, but seems again our ATH is far superior without the side effects of Donanemab and non intravenous application.
https://www.abc.net.au/news/2025-05-22/alzheimers-drug-donanemab-tga-approval-dementia/105319856
- Forums
- ASX - By Stock
- ATH
- Donanemab approved in Australia for treatment of Alzheimer's disease
ATH
alterity therapeutics limited
Add to My Watchlist
0.00%
!
1.4¢

Donanemab approved in Australia for treatment of Alzheimer's disease
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $128.9M |
Open | High | Low | Value | Volume |
1.3¢ | 1.4¢ | 1.3¢ | $49.17K | 3.596M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
41 | 22025579 | 1.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.4¢ | 2141193 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 36522 | 0.014 |
38 | 21571349 | 0.013 |
36 | 17098569 | 0.012 |
15 | 7706147 | 0.011 |
31 | 14714355 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 1547234 | 5 |
0.015 | 20206877 | 11 |
0.016 | 4283104 | 13 |
0.017 | 7408424 | 11 |
0.018 | 11761167 | 21 |
Last trade - 16.10pm 12/08/2025 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |